Intestinal tuberculosis

Summary

Intestinal tuberculosis (MONDO:0001678) is a disease and 5 clinical trials. A subtype of gastroenteritis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 5

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	intestinal tuberculosis
Mondo ID	MONDO:0001678
DOID	DOID:13282
ICD-10-CM	A18.32
SNOMED CT	60136008
UMLS	C0275911
MedGen	546943
GARD	0022987
Is cancer (heuristic)	no

Also known as: intestine tuberculosis · tuberculosis of intestine

Disease family

This is a subtype of gastroenteritis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › gastroenteritis › intestinal tuberculosis

Related subtypes (8): inflammatory diarrhea, intestinal infectious disease, colitis, appendicitis, campylobacteriosis, Salmonella gastroenteritis, eosinophilic gastroenteritis, enteritis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 5.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	5

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06629194	Not specified	RECRUITING	Validation of Scoring Systems for Differentiating Intestinal Tuberculosis from Crohn’s Disease
NCT07575061	Not specified	RECRUITING	A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal Tuberculosis
NCT01392365	Not specified	COMPLETED	Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn’s Disease
NCT01503099	Not specified	UNKNOWN	Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn’s Disease
NCT03096379	Not specified	COMPLETED	MRI Differentiating Gut TB and Crohn’s